Gavi's response

Respond and protect: With COVID-19 now reported in almost all Gavi-eligible countries, the Vaccine Alliance is providing immediate funding to health systems, enabling countries to protect health care workers, perform vital surveillance and training, and purchase diagnostic tests.

Maintain, restore and strengthen: Gavi will support countries to adapt and restart immunisation services, rebuild community trust and catch up those who have been missed both before and during the pandemic, while also investing in strengthening immunisation systems to be more resilient and responsive to the communities they serve.

Ensure global equitable access: Gavi is co-leading COVAX, the global effort to securing a global response to COVID-19 that is effective and fair, using its unique expertise to help identify and rapidly accelerate development, production and delivery of COVID-19 vaccines so that anyone that needs them, gets them.

COVID-19 vaccines

Accurate, evidence-based information about COVID-19 vaccines.

Learn more

Situation reports

Historical updates concerning the impact of and response to the COVID-19 pandemic in Gavi-supported countries.

COVAX Facility

Gavi is co-leading COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. This involves coordinating the COVAX Facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of eventual COVID-19 vaccines.

Learn more

COVAX Facility

Key news

7 July 2021

The COVID-19 vaccine race

Scientists around the world are working faster than ever to develop and produce vaccines that can stop the spread of COVID-19. Since the emergence of this novel coronavirus in December 2019, more than a dozen vaccines have started to be rolled…

15 October 2020

Taking the long view on vaccine markets

Gavi’s long-term approach to developing healthy markets for critical vaccines has led to greater stability and security, providing countries with the confidence that supplies will be available to meet their demand.

14 October 2020

2019 was a landmark year for countries co-financing their vaccine programmes

In 2019, a higher share of Gavi-supported countries than ever before met their co-financing obligations on time, thanks to strong political commitment.

13 October 2020

Strong systems for strong vaccine coverage

In 2019, countries delivered more than 230 million routine vaccinations, a record number, supported by unprecedented levels of health system funding from Gavi to support immunisation and protect the most vulnerable children. Here is what Gavi did…

28 September 2020

How market shaping works

The goal of our market shaping work is to help ensure vaccine markets work better for lower-income countries. We want the maximum number of people to receive the life-saving and health-protecting benefits of immunisation.

25 September 2020

Experimental approaches to address post-transition risks

After transitioning out of Gavi support in 2017, the Republic of Moldova is mobilising champions and advocates to strengthen vaccine confidence – which is crucial to the success and sustainability of immunisation programmes.

24 September 2020

Typhoid: immunising against antimicrobial resistance

Typhoid fever is increasingly resistant to the main antibiotics used to treat it. Gavi is supporting a new vaccine to help control this deadly disease – and fight antimicrobial resistance.

23 September 2020

Gavi at UNGA: Global solidarity to defeat COVID-19 and create a better world for all

September 2020 marks the 75th anniversary of the United Nations General Assembly (UNGA). This year, the focus of the high-level General Debate is the importance of effective multilateralism.

23 September 2020

Leaders in the fight against infectious diseases

Snapshots from DRC, India and Zambia illustrate country ownership and progress in the fights against Ebola, polio and HPV.

COVID-19 explored

View all

28 July 2021

Fighting liver cancer with vaccines in The Gambia

Vaccines against cancer may seem like a futuristic notion, but children around the world are already getting protection against two of the biggest causes of cervical and liver cancer: HPV and hepatitis B.

28 July 2021

Pandemic Culture: Painting for joy - and vaccine confidence - in California

As COVID-19 began to grip northern California, one furloughed lunch lady turned herself into the Velvet Bandit, a pandemic warrior spreading her pro-science message across the streets of the Golden State.

28 July 2021

Pandemic Culture

For most of us, the pandemic did not start with a close encounter with the virus. Instead, this new normal began when public life was suddenly snuffed out: streets emptied, squares and parks closed, shops and workplaces shuttered. But, even as…

28 July 2021

Is modern life encouraging the evolution of deadlier viruses?

The way we live can shape the evolution of pathogens, for better or worse.

27 July 2021

COVID masks: how and when to ask someone to wear one – without getting into a fight

Just because face coverings aren't mandatory doesn't mean they're not protective – so here's how to ask someone to wear one.

Last updated: 27 Apr 2021

Subscribe to our newsletter